Microbial Bioactives

1. Introduction

Marine sponges, members of the phylum Porifera, represent some of the oldest multicellular life forms on Earth. Fossil and biochemical evidence suggests that these animals first appeared approximately 700–800 million years ago, predating most major animal lineages (Li et al., 1998; Love et al., 2009). In today’s oceans, sponges inhabit nearly all marine environments—from sunlit coral reefs and intertidal flats to the cold, dark depths of the abyss (Spalding et al., 2007; Van Soest et al., 2012). Though lacking mobility and obvious physical defenses, sponges thrive through evolutionary innovation, most notably via chemical defenses and intimate associations with microbial partners that together form remarkably stable and productive ecosystems within sponge tissues.

Early naturalists and chemists noticed that sponges often accumulate unusual chemicals—but it was only in the mid-20th century that systematic exploration of sponge chemistry began. Bergmann and Burke’s pioneering work in 1955 identified sponge–derived nucleosides that later served as molecular templates in antiviral drug development (Bergmann & Burke, 1955). Over subsequent decades, chemical ecologists and natural products chemists documented hundreds of new compounds from sponges (Proksch et al, 2006; Brinkmann et al.,2010; Santos-Aberturas & Vior, 2022, Esteves et al., 2013). Yet, as analytical tools sharpened, so did our understanding of the true origin of many of these molecules: not the sponge itself, but the complex communities of microbes that live inside sponge tissues (Taylor, et al., 2007; Webster & Taylor, 2012). These microbial partners—bacteria, archaea, fungi, and microalgae—collectively form a holobiont with the host, contributing to its biology in fundamental ways.

Sponges and their microbial consortia defy simplistic ecological categorizations. In some species, microbial cells can constitute up to 60% of the animal’s biomass, creating a dense symbiotic ecosystem that rivals the host itself in both volume and function (Hentschel et al., 2002; Thomas, Kavlekar, & LokaBharathi, 2010). These communities are often highly specific to their sponge hosts and remain stable across vast geographic distances and over time (Erwin, et al., 2012; Hardoim & Costa, 2014). Indeed, the biology of sponge–microbe associations is governed by an interplay of host-mediated selection, microbial competition, and environmental filtering, yielding distinctive microbiomes that are taxonomically and functionally rich.

The acquisition of these symbionts can occur through multiple pathways. Vertical transmission—where microbes are passed directly from parent to offspring via reproductive stages such as larvae or oocytes—ensures that beneficial partners persist through generations (Schmitt et al., 2007). Horizontal acquisition, where the sponge selectively filters and retains microbes from seawater, also contributes to microbiome assembly (Webster & Taylor, 2012). These pathways are not mutually exclusive; rather, they reflect a dynamic and flexible symbiotic strategy that has evolved across sponge lineages.

At the heart of this partnership lies the remarkable biosynthetic capacity of sponge microbiomes. Culture-independent surveys reveal that sponge-associated microbes span at least fifteen phyla, including Proteobacteria, Actinobacteria, Cyanobacteria, Chloroflexi, and the candidate phylum Poribacteria, as well as archaea and fungi (Fieseler et al., 2004; Hardoim & Costa, 2014). Many of these taxa harbor biosynthetic gene clusters (BGCs) encoding enzymes for the production of secondary metabolites—compounds not directly required for growth but essential in defense, competition, and communication (Siegl & Hentschel, 2010; Osinga et al., 1999; Spalding et al., 2007; Van Soest et al., 2012). Indeed, polyketide synthase and nonribosomal peptide synthetase gene clusters, which are responsible for some of the most structurally diverse and bioactive natural products known, are abundant in sponge-associated genomes.

The pharmacological potential of these microbial metabolites is difficult to overstate. Systematic reviews of marine natural products consistently place sponges—and by extension, their symbionts—at the forefront of marine drug discovery, yielding more novel compounds than any other invertebrate group (Proksch et al., 2002; Wang, 2006). These compounds encompass diverse chemical classes, including alkaloids, polyketides, terpenoids, peptides, and hybrid structures. Their activities span anticancer, antimicrobial, antiviral, and antiparasitic effects, making them attractive scaffolds for drug development against diseases that continue to challenge global health.

One of the most celebrated examples of microbe-derived sponge metabolites is salinosporamide A, a potent proteasome inhibitor produced by Salinispora tropica, a marine actinomycete. Salinosporamide A has advanced into clinical trials for multiple myeloma, exemplifying how sponge microbiome research can translate into tangible therapeutic advances (Feling et al., 2003; Jagannathan et al., 2021). Another notable compound, manzamine A, originally discovered from sponge extracts, exhibits promising antimalarial activity in experimental models (Ang, Holmes, Higa, Hamann, & Kara, 2000). Similarly, sorbicillactone A—derived from a sponge-associated Penicillium fungus—has demonstrated antileukemic and antiviral activities, highlighting the biochemical creativity of fungal symbionts within sponge hosts (Bringmann et al., 2005; Hardoim & Costa, 2014).

The prominence of Actinobacteria as metabolite producers in sponge microbiomes is well established. These Gram-positive bacteria are renowned for their capacity to generate antibiotics and antitumor agents in terrestrial environments, and their marine counterparts continue this legacy in the oceans (Bérdy, 2005; Baltz, 2008). Proteobacteria and Cyanobacteria, while not as prolific as actinomycetes, also contribute unique compounds including antimicrobial agents and photoprotective pigments (Fieseler et al., 2004; Hentschel et al., 2002). Together, these diverse producers create a rich chemical landscape that both protects the sponge and provides a vault of molecules for human exploration.

Despite this promise, the field faces a significant challenge often called the “supply problem.” Many sponges are slow-growing organisms with fragile ecological roles, and harvesting them in large quantities for drug extraction is neither practical nor environmentally sustainable (Sipkema et al., 2005). To address this, researchers have explored alternative strategies. Mariculture—the farming of sponges in controlled sea conditions—has shown potential for sustainable biomass production, though it remains labor-intensive and variable in yield (Duckworth, et al., 1997; Osinga, et al, 1999). Cell culture offers another avenue, aiming to maintain sponge cells or symbiont cultures in vitro, yet technical barriers remain, particularly for complex, unculturable microbes (Rinkevich, 2005).

The rise of metagenomic approaches has been transformative. By sequencing the DNA directly from sponge tissues, scientists can uncover biosynthetic gene clusters from uncultivable symbionts and then clone these clusters into laboratory-friendly hosts for expression and compound production (Siegl & Hentschel, 2010). This approach bypasses the need to culture the original microbes or harvest sponge biomass, democratizing access to natural products. Moreover, genetic tools such as CRISPR–Cas9 have enabled targeted manipulation of microbial genomes to enhance metabolite production, offering a glimpse into a future where microbial factories can be engineered for optimal yields of desired compounds (Tong et al., 2015).

Ecological studies continue to illuminate how sponge microbiomes are structured and maintained. Quorum sensing and other chemical signaling pathways appear to play roles in community stability and defense, suggesting that communication among symbionts—and between microbes and host—may regulate metabolite production (Hardoim & Costa, 2014). Understanding these interactions not only enriches basic ecological knowledge but also guides practical efforts to sustain and manipulate these communities in laboratory or aquaculture settings.

The symbiotic relationship between marine sponges and their microbial consortia represents a remarkable evolutionary innovation with profound implications for human health. These ancient partnerships have forged a vast reservoir of bioactive chemistry, much of which remains untapped. Systematic reviews and meta-analyses of the literature reveal patterns in microbial diversity, metabolite production, and biosynthetic potential that inform both ecological theory and drug discovery practice. As technologies advance—from metagenomics to synthetic biology—the promise of sponge microbiomes as sources of new medicines grows ever more tangible. Unraveling and harnessing this chemical complexity may yield solutions to some of the most pressing medical challenges of our time, from multidrug-resistant infections to cancer and beyond.

2. Materials and Methods

2.1 Study Design and Review Framework

This study was conducted as a systematic review and proportion-based meta-synthesis investigating marine sponge–microbe symbioses and their contribution to secondary metabolite production, microbial diversity, and pharmaceutical discovery potential. The methodological framework was developed according to internationally recognized standards for evidence synthesis and systematic review reporting. The review process followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines to ensure methodological transparency, reproducibility, and structured reporting throughout the study selection and synthesis process (Page et al., 2021). The overall workflow of study identification, screening, eligibility assessment, and inclusion was summarized using a PRISMA flow diagram (Figure 1).

The primary objective of the review was to synthesize available evidence regarding (i) the diversity and

Figure 1: PRISMA 2020 Flow Diagram for Study Selection and Inclusion in the Systematic Review and Meta-Synthesis. This figure illustrates the sequential process of literature identification, duplicate removal, screening, eligibility assessment, and final inclusion of studies following PRISMA 2020 guidelines. The workflow summarizes the structured selection strategy used to synthesize evidence on marine sponge–microbe symbioses and bioactive metabolite discovery.

ecological stability of sponge-associated microbial communities, (ii) the biosynthetic potential of microbial symbionts, and (iii) the occurrence of bioactive secondary metabolites with pharmacological relevance. Because the included studies varied considerably in experimental design, microbial cultivation approaches, metabolite screening methods, and outcome reporting, a mixed narrative and quantitative synthesis strategy was adopted. This integrative approach allowed ecological and biochemical findings to be interpreted alongside proportion-based statistical summaries derived from microbial bioactivity screening studies.

2.2 Literature Search Strategy and Information Sources

A comprehensive literature search was conducted using multiple international scientific databases, including PubMed/MEDLINE, Scopus, Web of Science, and ScienceDirect. These databases were selected to ensure broad coverage of marine microbiology, biotechnology, microbial ecology, natural product chemistry, and pharmaceutical research. Search strategies combined controlled vocabulary terms and free-text keywords associated with marine sponges, microbial symbioses, and secondary metabolites.

The primary search terms included combinations of: “marine sponge,” “Porifera,” “sponge microbiome,” “microbial symbiosis,” “secondary metabolites,” “biosynthetic gene clusters,” “marine natural products,” “Actinobacteria,” “marine fungi,” “metagenomics,” and “drug discovery.” Boolean operators (“AND” and “OR”) were used to refine database retrieval. Additional manual screening of reference lists from review papers and foundational studies was also performed to identify potentially relevant publications not captured during electronic database searching.

Only peer-reviewed articles published in English were included. No strict lower publication date restriction was applied because several foundational studies from earlier decades remain highly influential in marine sponge microbiology and natural product research. All retrieved citations were exported into reference management software, where duplicate records were identified and removed prior to eligibility screening.

2.3 Eligibility Criteria and Study Selection

Studies were selected according to predefined inclusion and exclusion criteria developed before data extraction. Eligible studies included original research articles and comprehensive reviews focusing on marine sponge-associated microbial communities, microbial-derived secondary metabolites, biosynthetic pathways, or natural product discovery. Studies reporting microbial diversity, bioactive screening outcomes, metabolomic analyses, biosynthetic gene clusters, or pharmacological activities of sponge-associated microorganisms were considered eligible.

Studies focusing exclusively on freshwater sponges, non-microbial sponge physiology, or purely taxonomic sponge descriptions without biochemical or microbiological relevance were excluded. Conference abstracts, editorials, unpublished theses, and non-peer-reviewed sources were also excluded to maintain methodological consistency and data reliability.

The study selection process was conducted in two stages. Initially, titles and abstracts were screened for relevance based on the predefined criteria. Full-text articles of potentially eligible studies were then retrieved and independently evaluated. Any discrepancies regarding study inclusion were resolved through repeated critical assessment of study relevance, methodological clarity, and contribution to the objectives of the review.

2.4 Data Extraction and Study Variables

Data extraction was conducted using a standardized extraction framework designed to capture ecological, microbiological, and biochemical information from each included study. Extracted variables included sponge species, geographic sampling location, microbial taxa identified, total microbial isolates screened, number of bioactive isolates, metabolite classes detected, biosynthetic gene clusters identified, and reported biological activities.

Additional methodological details were also recorded, including microbial cultivation approaches, sequencing techniques, metabolomic platforms, and molecular analyses used for biosynthetic characterization. Particular attention was given to studies reporting bioactive screening success rates because these data were subsequently used for proportion-based quantitative synthesis and graphical interpretation.

The extracted information was organized into comparative summary tables to facilitate interpretation of microbial diversity patterns, metabolite distribution, and screening efficacy across sponge-associated microbial systems (Tables 1–3).

2.5 Quantitative Synthesis and Effect Size Estimation

To complement the narrative synthesis, a proportion-based meta-analytical approach was performed using microbial bioactivity screening outcomes reported across eligible studies. The primary effect size measure was the proportion of bioactive isolates relative to the total number of microbial isolates screened within each study. Proportion estimates, standard errors, and 95% confidence intervals were calculated for comparative interpretation and forest plot construction.

The analytical framework was guided by standard principles of meta-analysis described by Borenstein et al. (2009). Given the expected ecological and methodological heterogeneity among included studies, random-effects modeling principles were considered appropriate for interpretation of pooled trends, following the conceptual framework introduced by DerSimonian and Laird (1986). Random-effects approaches are particularly suitable for ecological and biological syntheses where variation among studies reflects both sampling error and genuine biological diversity.

Forest plot interpretation was used to evaluate the consistency and magnitude of bioactive screening outcomes among studies. Confidence intervals were examined to assess statistical precision, while proportional variability among sponge hosts and microbial groups was interpreted as a reflection of ecological and methodological heterogeneity.

2.6 Assessment of Heterogeneity and Publication Bias

Statistical heterogeneity among studies was interpreted using conceptual guidelines established for systematic reviews and meta-analyses. Variability in screening outcomes was evaluated qualitatively through comparison of proportional effect sizes, confidence intervals, and microbial diversity patterns across studies. The interpretation of heterogeneity was informed by the framework proposed by Higgins et al. (2003), which emphasizes the importance of inconsistency assessment when integrating biologically diverse datasets.

Potential publication bias and small-study effects were examined through funnel plot interpretation. Funnel plot symmetry was visually evaluated to determine whether smaller studies disproportionately reported extreme positive outcomes. The conceptual basis for this assessment followed the graphical bias detection approach described by Egger et al. (1997). Because the included studies differed substantially in experimental design and reporting structure, funnel plot interpretation was used primarily for qualitative assessment rather than strict statistical inference.

2.7 Quality Assessment and Methodological Appraisal

The methodological quality of included studies was evaluated using adapted criteria derived from systematic review guidance provided in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins et al., 2022). Although many included studies were ecological or microbiological rather than clinical investigations, several core principles remained applicable, including clarity of study design, transparency of data reporting, appropriateness of analytical methods, and consistency between reported findings and conclusions.

Studies demonstrating clear microbial identification procedures, reproducible metabolite screening methods, and comprehensive methodological descriptions were considered methodologically robust. Particular attention was given to the reliability of microbial cultivation strategies, metabolomic analyses, and biosynthetic interpretations. Studies with limited methodological detail or incomplete reporting were interpreted cautiously during synthesis.

2.8 Data Interpretation and Integrative Synthesis

The final synthesis integrated ecological, microbiological, and biochemical findings across all included studies. Comparative patterns in microbial diversity, metabolite production, and bioactive screening success were interpreted alongside taxonomic distributions and biosynthetic trends. Particular emphasis was placed on recurrent microbial groups such as Actinobacteria, Proteobacteria, and fungal symbionts due to their repeated association with pharmacologically relevant secondary metabolites.

The combined narrative and quantitative synthesis approach enabled interpretation of both biological complexity and statistical trends within sponge-associated microbial systems. This integrative framework provided a comprehensive understanding of how marine sponge microbiomes contribute to natural product discovery, microbial ecology, and emerging marine biotechnology applications.

3. Results

3.1 Patterns of Microbial Diversity and Secondary Metabolite Production in Marine Sponge Holobionts

The systematic synthesis of the included literature revealed consistent patterns linking marine sponge–microbe symbioses with enhanced biosynthetic diversity, bioactive metabolite production, and pharmaceutical potential. Across the screened studies, sponge-associated microbial communities demonstrated substantial variability in taxonomic composition and bioactive screening success, yet several recurring ecological and biochemical trends emerged. The PRISMA-guided workflow used for study identification, screening, eligibility assessment, and final inclusion is presented in Figure 1, illustrating the structured selection of studies used in this review.

The compiled evidence showed that marine sponges consistently harbor dense and metabolically active microbial consortia, reinforcing earlier ecological observations that sponge holobionts function as highly integrated microbial ecosystems (Hentschel et al., 2002; Taylor et al., 2007). Across the included studies, bacterial and fungal isolates recovered from sponge tissues demonstrated markedly different frequencies of bioactive activity depending on host species and microbial group. The screening outcomes summarized in Table 1 indicate that bioactive “hit” rates ranged from as low as 8.0% in epibiotic bacteria associated with Ircinia fusca to as high as 67.8% in bacterial isolates recovered from Ircinia wistarii. These findings suggest that sponge species differ considerably in their capacity to support metabolically productive microbial populations.

Among the studies included in Table 1, the highest proportion of bioactive isolates was reported by Wilkinson (1978), where 59 out of 87 bacterial isolates demonstrated detectable activity, corresponding to an efficacy rate of 67.8%. In contrast, Thakur et al. (2004) reported substantially lower screening success in epibiotic bacteria from Ircinia fusca, with only 2 bioactive isolates among 25 cultured strains. Intermediate success rates were observed in studies involving Ircinia strobilina, Psammocinia species, and Hymeniacidon perlevis, where efficacy values ranged between approximately 16% and 28% (Paz et al., 2010; Zan et al., 2011; Zhang et al., 2005). Collectively, these patterns indicate that microbial bioactivity is unevenly distributed among sponge-associated communities and may reflect differences in host physiology, microbial selection processes, and environmental adaptation (Table 1).

The distribution of microbial taxa associated with natural product biosynthesis further highlighted the dominance of specific bacterial and fungal groups in marine sponge systems. As summarized in Table 2 and visualized in Figure 4, Actinobacteria accounted for the largest proportion of reported bacterial-derived bioactive compounds, contributing approximately 46.66% of identified metabolites. These taxa were repeatedly associated with antimicrobial and antitumor activities, supporting previous observations regarding the exceptional biosynthetic capacity of marine actinomycetes (Baltz, 2008; Grasso et al., 2021). Proteobacteria represented the second-largest bacterial contributor, accounting for 23.33% of compounds and exhibiting notable antibiotic and anti-HIV potential. Smaller yet significant contributions were observed from Firmicutes, Cyanobacteria, and Verrucomicrobia, indicating that metabolite production is distributed across multiple phylogenetic lineages rather than restricted to a single dominant group.

Fungal symbionts also emerged as important contributors to sponge-associated chemical diversity. Within the fungal division, Ascomycota represented the most prominent group, accounting for approximately 73.04% of reported fungal-derived compounds (Table 2). These metabolites were frequently associated with antileukemic and antiviral properties, reinforcing the growing recognition of sponge-associated fungi as reservoirs of pharmacologically valuable secondary metabolites (Bringmann et al., 2005; Hardoim & Costa, 2014). Figure 4 further illustrates the uneven distribution of metabolite-producing taxa, with strong dominance by Actinobacteria and Ascomycota compared with less represented microbial groups. This taxonomic imbalance suggests that future bioprospecting efforts may continue to prioritize these groups while simultaneously exploring underrepresented lineages for novel chemistry.

The comparative patterns presented in Figure 2 demonstrate substantial variation in bioactive screening success rates across studies. Although all included investigations identified at least some metabolically active isolates, the magnitude of success varied considerably depending on microbial origin and cultivation strategy.

Table 1. Bioactive Screening Success Rates Among Sponge-Associated Microbial Isolates. This table summarizes the proportion of bioactive microbial isolates recovered from sponge-associated communities. Efficacy (%) reflects the frequency of bioactive “hits” relative to total isolates screened, highlighting variability across host species and microbial groups. The data demonstrate substantial differences in discovery success rates, supporting targeted bioprospecting strategies.

Table 2. Taxonomic Distribution of Bioactive Compounds in Marine Microbial Sources. This table presents the distribution of bioactive compound production across microbial taxa. Percentages indicate relative contributions to natural product discovery, revealing strong dominance by Actinobacteria and fungal groups. The data highlight potential taxonomic bias and guide future exploration of underrepresented microbial lineages.

Table 3. Proportion-Based Effect Sizes of Bioactive Screening Success in Sponge-Associated Microbial Isolates. This table presents proportion-based effect sizes of bioactive screening success across sponge-associated microbial isolates. Proportions (p), standard errors (SE), and confidence intervals (CI) are included for meta-analysis and forest plot construction. Variability in success rates reflects differences in host species, microbial groups, and cultivation strategies.

Higher efficacy values were generally associated with studies employing broader microbial cultivation approaches or targeting diverse bacterial assemblages, whereas lower success rates were more commonly observed in narrowly focused epibiotic or host-specific investigations. These observations imply that methodological diversity and sampling breadth may strongly influence the recovery of bioactive microorganisms from sponge systems.

Similarly, Figure 3 reinforces the variability observed across microbial screening studies by illustrating proportional differences in bioactive isolate recovery among sponge hosts and microbial groups. While certain sponge species consistently yielded high proportions of active isolates, others demonstrated comparatively modest biosynthetic outputs. Such heterogeneity likely reflects the combined effects of host phylogeny, microbial competition, environmental conditions, and nutrient availability within sponge tissues (Erwin et al., 2012; Webster & Taylor, 2012). Despite this variability, the overall trends consistently support the interpretation that sponge-associated microbiomes constitute biologically enriched reservoirs of secondary metabolite production.

The meta-synthetic interpretation of bioactive screening outcomes was further strengthened by the proportion-based effect size analysis summarized in Table 3. The calculated proportions and confidence intervals reveal notable differences in the likelihood of recovering bioactive isolates across studies. For example, Hymeniacidon perlevis displayed one of the highest proportional success rates, with a calculated effect size of 0.276, whereas Ircinia fusca demonstrated a substantially lower value of 0.08. Studies involving Psammocinia species and Ircinia strobilina showed intermediate effect sizes, suggesting moderate but consistent biosynthetic productivity among associated microbial taxa.

The confidence intervals reported in Table 3 additionally highlight the influence of sample size and cultivation variability on screening precision. Studies with relatively small isolate numbers displayed broader confidence intervals, reflecting greater uncertainty in estimated proportions. In contrast, investigations involving larger microbial collections, such as the study by Hardoim et al. (2014), demonstrated improved statistical stability due to expanded sampling coverage. Nevertheless, even with methodological variability, the collective findings indicate that sponge-associated microorganisms consistently exhibit measurable biosynthetic activity across geographically and taxonomically diverse systems.

A broader ecological pattern also emerged from the integrated synthesis of microbial diversity and metabolite distribution. Sponge-associated microbiomes appeared to contain highly specialized microbial assemblages that were repeatedly linked to chemically productive taxa, particularly Actinobacteria, Proteobacteria, and fungal symbionts. These findings align with previous molecular and ecological investigations demonstrating that sponge hosts selectively maintain stable microbial communities with functional biosynthetic roles (Taylor et al., 2007; Schmitt et al., 2007). The repeated detection of PKS- and NRPS-associated microbial groups across multiple studies further supports the interpretation that sponge microbiomes are enriched in organisms capable of producing structurally complex secondary metabolites (Siegl & Hentschel, 2010).

The cumulative evidence synthesized in this review therefore suggests that marine sponges function not only as ecological habitats but also as highly productive biochemical reservoirs. Across the included studies, sponge-associated microbes repeatedly demonstrated substantial pharmacological potential, particularly in relation to antimicrobial, antiviral, antifungal, antitumor, and cytotoxic activities. The consistent recovery of bioactive isolates from phylogenetically distinct microbial groups reinforces the concept that metabolite production is a defining functional feature of sponge holobionts rather than an isolated characteristic of a few specialized taxa.

Importantly, the results also reveal that methodological advances have significantly expanded the capacity to detect and characterize sponge-associated microbial metabolites. Earlier investigations relied primarily on cultivation-based isolation techniques, whereas more recent studies increasingly integrate molecular ecology, metagenomics, and genome-mining approaches to identify biosynthetic pathways and previously uncultivable symbionts (Thomas et al., 2010; Tong et al., 2015). This technological progression has broadened the detectable biosynthetic landscape of sponge microbiomes and strengthened the recognition of microbial symbionts as primary contributors to sponge-derived natural products.

Overall, the findings collectively demonstrate that sponge–microbe symbioses represent evolutionarily stable and chemically productive systems with considerable

Figure 2. Comparative Bioactive Screening Success Rates Among Sponge-Associated Microbial Studies. This figure presents the percentage of bioactive microbial isolates recovered across different sponge-associated microbial screening studies. Variability in screening efficacy reflects differences in host sponge species, microbial diversity, cultivation approaches, and metabolite detection strategies.

Figure 3. Forest Plot of Proportion-Based Bioactive Screening Outcomes in Sponge-Associated Microbial Isolates. This figure illustrates proportion-based effect sizes and confidence intervals for bioactive isolate recovery among sponge-associated microbial communities. The forest plot highlights heterogeneity in biosynthetic activity across sponge hosts and microbial groups included in the meta-synthesis.

biomedical significance. The integrated interpretation of Table 1, Table 2, and Table 3 together with Figures 1–5 supports the conclusion that marine sponge microbiomes constitute highly promising reservoirs of bioactive secondary metabolites with substantial relevance for future drug discovery and marine biotechnology research.

3.2 Interpretation and Discussion of Forest and Funnel Plots

The forest and funnel plot analyses provide important insight into the consistency, reliability, and interpretive strength of the studies included in this systematic synthesis of marine sponge–microbe symbioses. Together, these graphical approaches help evaluate the distribution of bioactive screening outcomes, the variability among included investigations, and the overall robustness of the observed associations between sponge-associated microorganisms and secondary metabolite production. The comparative trends summarized in Figure 2 and Figure 3 demonstrate that bioactive screening success rates varied considerably among sponge hosts and microbial groups, yet the direction of the findings remained consistently supportive of strong biosynthetic potential within sponge-associated microbiomes.

The forest plot interpretation derived from the proportional effect size data presented in Table 3 indicates that most included studies reported positive bioactivity outcomes, although the magnitude of those outcomes differed substantially between investigations. Studies involving Hymeniacidon perlevis and Ircinia strobilina demonstrated comparatively higher effect sizes and broader bioactive recovery, whereas lower proportions were observed in studies involving epibiotic bacterial isolates from Ircinia fusca (Thakur et al., 2004; Zhang et al., 2005; Zan et al., 2011). This variability is visually reflected in Figure 2, where substantial differences in screening efficacy can be observed across individual studies and microbial groups. Despite the dispersion in proportional values, the majority of effect estimates remained on the positive side of the pooled interpretation, suggesting that sponge-associated microorganisms consistently exhibit measurable bioactive potential.

The width of the confidence intervals reported in Table 3 further illustrates the influence of sample size and methodological heterogeneity on estimate precision. Smaller studies with limited isolate numbers generally produced wider confidence intervals, indicating greater statistical uncertainty, while larger studies involving broader microbial collections yielded comparatively narrower intervals and more stable estimates. For instance, studies involving extensive cultured bacterial collections from Irciniidae sponges displayed more consistent proportional outcomes than smaller-scale epibiotic surveys. Nevertheless, even studies with broader intervals continued to support the overall pattern of detectable biosynthetic activity among sponge-associated microbial communities.

The observed heterogeneity among studies likely reflects the ecological complexity of sponge holobionts and the methodological diversity employed across investigations. Variations in cultivation conditions, microbial isolation strategies, sequencing depth, and metabolomic screening platforms can all influence the proportion of detectable bioactive isolates. Environmental differences among sampling sites, including nutrient availability, temperature, salinity, and host-specific ecological niches, may further contribute to variability in microbial composition and metabolite production (Hardoim & Costa, 2014; Taylor et al., 2007). However, the persistence of positive bioactivity trends across geographically distinct sponge species suggests that the overall relationship between sponge-associated microbes and natural product biosynthesis remains biologically robust.

The funnel plot interpretation provides an additional layer of confidence regarding the reliability of the synthesized findings. The overall distribution of studies appears relatively symmetrical, with no strong indication that only highly positive investigations were preferentially represented. This suggests a relatively limited influence of publication bias within the included literature. Smaller studies exhibited greater dispersion, which is expected in ecological and microbiological investigations where sampling intensity and cultivation success can vary substantially. However, there was no consistent tendency for smaller studies to report disproportionately inflated bioactivity estimates. Instead, the overlap between small- and large-scale investigations supports the reproducibility of the overall conclusions.

The patterns illustrated in Figure 3 further reinforce the interpretation of stable and recurrent biosynthetic activity across sponge-associated microbial communities. The repeated detection of bioactive isolates among phylogenetically diverse microbial groups—including Actinobacteria, Proteobacteria, and fungal

Figure 4. Taxonomic Distribution of Bioactive Compound-Producing Microbial Groups Associated with Marine Sponges. This figure demonstrates the relative contribution of major microbial taxa to bioactive secondary metabolite production within marine sponge microbiomes. Dominance by Actinobacteria and fungal Ascomycota emphasizes their importance in marine natural product discovery and pharmaceutical bioprospecting.

Figure 5. Relative Contribution of Sponge-Associated Microbial Taxa to Marine Natural Product Discovery and Therapeutic Potential. This figure summarizes the proportional representation of microbial groups linked to pharmacologically relevant secondary metabolites in marine sponge ecosystems. The distribution highlights recurring biosynthetic enrichment among bacterial and fungal symbionts with antimicrobial, antiviral, and antitumor potential.

symbionts—indicates that metabolite production is not restricted to isolated taxa but rather represents a widespread functional trait within sponge microbiomes. Similarly, the taxonomic distributions shown in Figure 4 and Figure 5 demonstrate that chemically productive microbial lineages consistently dominate marine natural product discovery datasets, particularly among Actinobacteria and Ascomycota-associated fungi.

Overall, the combined interpretation of the forest and funnel plot patterns supports the conclusion that sponge-associated microbial consortia represent statistically consistent and biologically meaningful reservoirs of bioactive secondary metabolites. Although methodological heterogeneity remains present across studies, the repeated observation of positive screening outcomes, stable proportional trends, and recurrent taxonomic enrichment collectively strengthens the reliability of the synthesized evidence and reinforces the growing importance of sponge microbiomes in marine biotechnology and drug discovery research.

4. Discussion

4.1 Evolutionary and Biotechnological Significance of Sponge-Associated Microbial Communities

The present synthesis reinforces the growing recognition that marine sponges function not merely as passive benthic organisms, but as highly integrated holobiont systems sustained by metabolically versatile microbial consortia. The combined interpretation of the Introduction, Results, Tables 1–3, and Figures 1–5 demonstrates that sponge-associated microorganisms contribute substantially to the ecological stability, biochemical diversity, and pharmaceutical relevance of marine sponge communities. The observed dominance of bioactive bacterial and fungal taxa, together with consistently positive screening outcomes across studies, supports the hypothesis that sponge microbiomes represent evolutionarily optimized reservoirs of secondary metabolite production (Taylor et al., 2007; Webster & Taylor, 2012).

One of the most striking findings emerging from this synthesis is the remarkable variability in bioactive screening success across sponge hosts and microbial groups. As shown in Table 1 and illustrated in Figure 2, efficacy rates ranged from 8.0% in epibiotic bacteria associated with Ircinia fusca to nearly 68% in bacterial isolates recovered from Ircinia wistarii. Such variability likely reflects differences in host phylogeny, microbial selection mechanisms, and environmental adaptation. Sponges are known to selectively recruit and maintain distinct microbial assemblages through a combination of physical filtration, immune recognition, and chemical signaling processes (Hentschel et al., 2002; Hardoim & Costa, 2014). Consequently, the observed differences in bioactive isolate recovery may not simply represent methodological variation, but rather genuine ecological distinctions among sponge holobionts.

The consistent recovery of bioactive microorganisms across geographically and taxonomically distinct sponge species also suggests that secondary metabolite production is a conserved functional feature within sponge-associated microbiomes. Figure 3 further highlights this pattern by demonstrating recurring proportional differences in microbial screening success among host species. Previous molecular studies have shown that many sponge-associated microbial communities remain remarkably stable across time and space, indicating strong host-mediated selection and co-evolutionary maintenance of symbiotic relationships (Erwin et al., 2012; Schmitt et al., 2007). The persistence of these associations over evolutionary timescales may explain why marine sponges continue to represent one of the richest sources of natural products discovered to date (Proksch et al., 2002; Wang, 2006).

The taxonomic distribution patterns summarized in Table 2 and visualized in Figure 4 provide further insight into the biosynthetic architecture of sponge microbiomes. Actinobacteria emerged as the dominant bacterial contributors to marine bioactive compound discovery, accounting for nearly half of all reported metabolites. This observation aligns closely with earlier reports emphasizing the extraordinary metabolic versatility of marine actinomycetes and their importance in antibiotic and antitumor drug discovery (Baltz, 2008; Jagannathan et al., 2021). Many actinomycetes harbor extensive polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) biosynthetic pathways capable of generating structurally diverse compounds with potent biological activities (Siegl & Hentschel, 2010; Rego et al., 2020). The strong representation of Actinobacteria within sponge microbiomes therefore reinforces the growing interest in marine-derived actinomycetes as next-generation pharmaceutical resources.

Proteobacteria also contributed substantially to the overall biosynthetic landscape, particularly in relation to antimicrobial and antiviral activities. Members of this group are frequently associated with quorum sensing, nutrient cycling, and host-defense interactions within sponge tissues (Taylor et al., 2007). Their repeated occurrence in studies reporting anti-HIV and antibacterial compounds suggests that these microorganisms may play multifunctional ecological roles while simultaneously contributing to the sponge’s chemical defense system. Similarly, Cyanobacteria and Firmicutes, although less dominant than Actinobacteria, demonstrated notable contributions to toxin production, pigmentation, and antifungal activities (Table 2). Together, these findings suggest that sponge-associated metabolite production is distributed across phylogenetically diverse microbial lineages rather than concentrated within a single dominant taxon.

An equally important observation emerging from this review is the substantial contribution of fungal symbionts to marine natural product diversity. The disproportionately high representation of Ascomycota-derived compounds shown in Table 2 and Figure 4 emphasizes the biochemical significance of sponge-associated fungi. Compounds such as sorbicillinoid alkaloids and related fungal metabolites have demonstrated strong antiviral, antileukemic, and cytotoxic properties, highlighting the therapeutic promise of fungal symbionts within sponge ecosystems (Bringmann et al., 2005; Hardoim & Costa, 2014). These observations further challenge earlier assumptions that sponges themselves were the primary biosynthetic producers of marine natural products. Instead, accumulating evidence increasingly supports the interpretation that many bioactive compounds are synthesized by microbial symbionts residing within sponge tissues (Taylor et al., 2007; Thomas et al., 2010).

The evolutionary implications of these findings are also noteworthy. Fossil evidence suggests that marine sponges emerged during the Precambrian and Cryogenian periods, making them among the oldest surviving metazoan lineages on Earth (Li et al., 1998; Love et al., 2009). The persistence of highly specialized microbial associations within these ancient organisms suggests that sponge–microbe symbioses have undergone prolonged evolutionary refinement. Such long-term co-evolution may explain the remarkable chemical complexity observed within sponge holobionts today. Indeed, many secondary metabolites likely evolved initially as ecological defense molecules involved in microbial competition, predator deterrence, and communication before later being recognized for their pharmaceutical utility in human medicine (Bérdy, 2005; Hentschel et al., 2002).

The findings summarized in Table 3 additionally demonstrate that bioactive screening outcomes remain statistically consistent despite methodological heterogeneity across studies. Although confidence intervals varied according to sample size and cultivation strategy, most effect estimates remained positive, supporting the interpretation that sponge-associated microbes consistently possess measurable biosynthetic potential. Figure 2 and Figure 3 collectively reinforce this conclusion by illustrating that positive bioactivity outcomes were observed across nearly all included studies regardless of geographic origin or microbial group. Such consistency strengthens confidence in the overall biological relevance of sponge-associated microbial metabolites and suggests that observed trends are unlikely to represent isolated or study-specific artifacts.

At the same time, this synthesis also highlights several continuing methodological and translational challenges. One major limitation remains the difficulty of cultivating many sponge-associated microorganisms under laboratory conditions. Numerous symbionts remain unculturable using conventional techniques, restricting direct access to their biosynthetic pathways and metabolites (Rinkevich, 2005; Sipkema et al., 2005). Moreover, metabolite production often depends on highly specific ecological interactions within the sponge microenvironment, making ex situ reproduction difficult. Environmental parameters such as temperature, nutrient availability, salinity, and microbial competition can all influence secondary metabolite expression, potentially contributing to variability in bioactive screening success among studies (Duckworth et al., 1997; Wang, 2006).

Recent advances in metagenomics, genome mining, and synthetic biology, however, are beginning to overcome these barriers. As discussed in both the Introduction and Results sections, molecular approaches now enable the detection and characterization of biosynthetic gene clusters directly from uncultured microbial communities (Siegl & Hentschel, 2010). The integration of CRISPR–Cas9 engineering, heterologous expression systems, and genome-guided metabolite discovery has expanded opportunities for sustainable production of marine natural products without excessive sponge harvesting (Tong et al., 2015). In this context, Figure 5 highlights the increasing importance of microbiome-centered biotechnological approaches in modern marine drug discovery. These emerging strategies may ultimately resolve the long-standing “supply problem” that has historically limited clinical translation of marine sponge-derived compounds.

Overall, the present synthesis demonstrates that marine sponge microbiomes represent highly specialized, evolutionarily stable, and pharmacologically valuable ecosystems. The integrated interpretation of Tables 1–3 together with Figures 1–5 strongly supports the concept that microbial symbionts are central drivers of sponge-associated chemical diversity. Continued integration of ecological, genomic, metabolomic, and synthetic biology approaches will therefore be essential for fully unlocking the therapeutic potential of marine sponge holobionts. Beyond their ecological significance, these ancient symbiotic systems may provide critical solutions to some of the most pressing biomedical challenges of the modern era, including antimicrobial resistance, emerging viral diseases, and the ongoing need for structurally novel anticancer agents.

5. Limitations

Several limitations should be acknowledged when interpreting the findings of this review. First, the included studies differed substantially in cultivation strategies, sequencing depth, metabolomic analyses, and microbial screening methodologies, introducing unavoidable methodological heterogeneity across datasets. Although proportion-based synthesis and forest plot interpretation provided comparative insight, variability in experimental design may influence the precision of pooled ecological interpretations. Second, many sponge-associated microorganisms remain unculturable under laboratory conditions, limiting direct confirmation of biosynthetic activity and restricting access to potentially important metabolites. Third, environmental factors such as salinity, nutrient availability, geographic location, and seasonal variation can strongly influence sponge microbiome composition and metabolite production, making cross-study comparisons inherently complex. In addition, several included studies reported relatively small sample sizes, which may broaden confidence intervals and reduce statistical stability. Finally, the review primarily relied on published English-language literature, raising the possibility of publication bias and exclusion of potentially relevant regional studies or unpublished datasets related to marine sponge biotechnology.

6. Conclusion

Marine sponge–microbe symbioses represent highly specialized evolutionary partnerships with exceptional biosynthetic and pharmaceutical significance. The evidence synthesized in this review demonstrates that sponge-associated microbial communities consistently contribute to the production of structurally diverse and biologically potent secondary metabolites. Advances in metagenomics, genome mining, and synthetic biology are now expanding access to previously hidden microbial chemistry while reducing dependence on unsustainable sponge harvesting. Although ecological complexity and cultivation barriers remain important challenges, sponge microbiomes continue to emerge as promising reservoirs for future antimicrobial, antiviral, and anticancer drug discovery. Integrating ecological, molecular, and biotechnological approaches will be essential for translating this immense marine biochemical diversity into clinically and environmentally sustainable therapeutic innovation.

References